NOV 13, 2017 3:19 PM PST

Improving the Detection of Fragile-X Syndrome

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

Repeat sequences are common in our DNA, and are known to cause human disorders. In particular, a triplet repeat on the X-chromosome is associated with Fragile X syndrome, a collection of abnormalities linked to intellectual disabilities and autism.
 
Because this disorder is a result of repeating nucleotide triplets, diagnosis hinges on knowing precisely how many repeats are present in the patient’s DNA. But current technologies make accurate genetic diagnosis for Fragile X Syndrome (FXS), and other repeat disorders, are complicated and expensive. Now, researchers at the National Institute of Health have unveiled platform that overcomes these obstacles, providing accurate FXS diagnoses in less than 24 hours.

In FXS, the trinucleotide repeat (CGG) is located in the FMR1 gene (aptly named as the fragile X mental retardation 1 gene). For FXS and other repeat disorders, the range of clinical severity is directly associated with the repeat length. Although the exact number of repeats in each range is not concrete, we know that people with between 5-40 repeats do not manifest any symptoms and are considered normal. Patients that have greater than 200 repeats are considered to have a full mutation and clinically develop FXS. However, patients that do not have that high repeat threshold but are above the normal repeat threshold, i.e. between 55-200 CGG repeats, are considered carriers of the permutation and develop Fragile X Tremor/Ataxia Syndrome. 
 
Another important characteristic of these disorders is the instability of these triplet repeats. This means the repeats often increase in length when transmitted to successive generations. Thus, there is genetic anticipation for triplet repeat expansion diseases, making it imperative for patients to know if they are carriers or not.
 
"Careful analysis of the total number of repeats, the number of interruptions in the repeat tract, and the methylation status of the FMR1 gene is important for a proper understanding of an individual's risk of transmission of larger alleles to their offspring and to their personal risk of disease pathology. It is also critical for addressing a number of important research questions," said Karen Usdin, scientist at the NIH and senior author of the study.


Current tests that attempt to amplify the long triplet repeat tracts are difficult and time-consuming. But with the new assays developed by Usdin and her team, the tests are robust enough to amplify up to 1,000 repeats even in samples that have a mixture of different alleles. Furthermore, accurate triplet repeats can be assayed in under 24 hours. In addition, "The basic assays for repeat number, methylation status, and the number of uninterrupted repeats cost less than $5, the mark typically considered the threshold for population-based screening," said Bruce Hayward, first author of the study.
 
The team hopes this assay will also be beneficial to researchers interested in the effect of repeat length in embryonic development and gene expression. It would also be interesting to know if a similar test can be applied to other repeat disorders, like Huntington’s disease.

Additional source: EurekAlert!

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 06, 2020
Clinical & Molecular DX
Your Earwax Says You're Depressed
NOV 06, 2020
Your Earwax Says You're Depressed
Cortisol, commonly known as the “stress hormone”, is the body’s built-in alarm system that sends siren ...
NOV 09, 2020
Genetics & Genomics
Potential Problems with Liquid Biopsies
NOV 09, 2020
Potential Problems with Liquid Biopsies
Liquid biopsies are tests that look for biomarkers in the blood, which can help inform the treatment of cancer. The tool ...
JAN 14, 2021
Clinical & Molecular DX
Tip of the Iceberg: Inaccuracies in Prostate Cancer Diagnostics
JAN 14, 2021
Tip of the Iceberg: Inaccuracies in Prostate Cancer Diagnostics
  Only 10 percent of icebergs are visible on the surface of the water; the remaining 90 percent remains submerged. ...
JAN 13, 2021
Clinical & Molecular DX
E-Stethoscope Picks up Good (and Bad) Vibrations
JAN 13, 2021
E-Stethoscope Picks up Good (and Bad) Vibrations
A medical device used to survey lung sounds to monitor for signs of respiratory distress has received FDA clearance. RES ...
FEB 09, 2021
Clinical & Molecular DX
Make Tissues Transparent to Spot Hidden Tumors, Let Machines Do the Rest
FEB 09, 2021
Make Tissues Transparent to Spot Hidden Tumors, Let Machines Do the Rest
A clearly defined border differentiates benign tumors from malignant ones. Malignant tumors start to get fuzzy around th ...
FEB 23, 2021
Genetics & Genomics
New Insight Into Genetic Basis of IBD From African-American Patients
FEB 23, 2021
New Insight Into Genetic Basis of IBD From African-American Patients
The small variations in the genome that lead to differences in biology, including risk for diseases, can't be assumed to ...
Loading Comments...